Campbell & Co. Investment Adviser »

Beam Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-09-30 $403k 17k 24.27
2025-06-30 $3.9M 227k 17.01

More positions owned by Campbell & Co. Investment Adviser

Wheaton Precious Metals Corp Common Stock (WPM)
Rio Tinto Adr (RIO)
Sprouts Farmers Market Common Stock (SFM)
PTC Common Stock (PTC)
Agnico Eagle Mines Common Stock (AEM)
OGE Energy Corp Common Stock (OGE)
Paychex Common Stock (PAYX)
CMS Energy Corp Common Stock (CMS)
Royal Gold Common Stock (RGLD)
Logitech International SA Common Stock (LOGI)
Franklin Resources Common Stock (BEN)
Meta Platforms Common Stock (META)
Graphic Packaging Holding Common Stock (GPK)
Kinder Morgan Common Stock (KMI)
Pan American Silver Corp Common Stock (PAAS)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Beam Therapeutics

FMR
ARK Investment Management
Farallon Capital Management
Vanguard Group
BlackRock
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Arch Venture Corp
State Street Corporation
Bellevue Group
Kynam Capital Management
Geode Capital Management
MWG Management
Dimensional Fund Advisors
Ubs Global Asset Management Americas

View all funds holding Beam Therapeutics